Cystic precursors to invasive pancreatic cancer

Nature Reviews Gastroenterology and Hepatology

Volumn 8, Issue 3, 2011, Pages 141-150

  Matthaei, Hanno ^a   Schulick, Richard D ^b   Hruban, Ralph H ^a   Maitra, Anirban ^a  

^a Sol Goldman Pancreatic Cancer Research Center   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; K RAS PROTEIN; MUCIN 1; MUCIN 2; MUCIN 5AC; PROTEIN KINASE LKB1; SMAD4 PROTEIN; TRANSCRIPTION FACTOR CDX2;

ASPIRATION BIOPSY; CANCER GROWTH; CANCER INVASION; CANCER MORPHOLOGY; CANCER RISK; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; CYST FLUID; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE MARKER; ENDOSCOPIC BIOPSY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MOLECULAR PATHOLOGY; MUCINOUS CYSTIC NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS CYST; PATHOLOGICAL ANATOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL TIME; TRANSLATIONAL RESEARCH;

ADENOCARCINOMA; DISEASE PROGRESSION; HUMANS; NEOPLASM INVASIVENESS; PANCREATIC CYST; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 79952423651     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2011.2     Document Type: Review

References (94)

1. Brugge, W. R. et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 126, 1330-1336 (2004). (Pubitemid 38552797)
2. Fernández-del Castillo, C et al. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch. Surg. 138, 427-434 (2003). (Pubitemid 36417680)
3. Spinelli, K. S. et al. Cystic pancreatic neoplasms: observe or operate. Ann. Surg. 239, 651-659 (2004). (Pubitemid 38525636)
4. Winter, J. M. et al. Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis. Ann. Surg. 243, 673-683 (2006).
5. Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117 (2010).
6. Tanaka, M. et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6, 17-32 (2006).
7. Park, W. G. et al. Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts. Pancreas 40, 42-45 (2011).
8. Tang, R. S. et al. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin. Gastroenterol. Hepatol. 6, 815-819 (2008). (Pubitemid 351888940)
9. Sawhney, M. S. et al. International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas. Clin. Gastroenterol. Hepatol. 7, 1373-1376 (2009).
10. Winter, J. M. et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J. Gastrointest. Surg. 10, 1199-1211 (2006). (Pubitemid 44781200)
11. Ikeda, M. et al. Morphologic changes in the pancreas detected by screening ultrasonography in a mass survey, with special reference to main duct dilatation, cyst formation, and calcification. Pancreas 9, 508-512 (1994). (Pubitemid 24191719)
12. Zhang, X. M., Mitchell, D. G., Dohke, M., Holland, G. A. & Parker, L. Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology 223, 547-553 (2002). (Pubitemid 34454341)
13. Lee, K. S., Sekhar, A., Rofsky, N. M. & Pedrosa, I. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am. J. Gastroenterol. 105, 2079-2084 (2010).
14. Laffan, T. A. et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am. J. Roentgenol. 191, 802-807 (2008).
15. Kimura, W., Nagai, H., Kuroda, A., Muto, T. & Esaki, Y Analysis of small cystic lesions of the pancreas. Int. J. Pancreatol. 18, 197-206 (1995). (Pubitemid 26023501)
16. Ohhashi, K., Murakami, F. & Maruyama, M. Four cases of mucous secreting pancreatic cancer. Prog. Dig. Endosc 203, 348-351 (1982).
17. Belyaev, O. et al. Intraductal papillary mucinous neoplasms of the pancreas. J. Clin. Gastroenterol. 42, 284-294 (2008). (Pubitemid 351301495)
18. Bassi, C., Sarr, M. G., Lillemoe, K. D. & Reber, H. A. Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management. J. Gastrointest Surg. 12, 645-650 (2008).
19. Tanaka, M., Kobayashi, K., Mizumoto, K. & Yamaguchi, K. Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas. J. Gastroenterol. 40, 669-675 (2005). (Pubitemid 41349077)
20. Schmidt, C M. et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology Ann. Surg. 246, 644-651 (2007). (Pubitemid 47480616)
21. Furukawa, T. et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 447, 794-799 (2005). (Pubitemid 41728866)
22. Yonezawa, S., Nakamura, A., Horinouchi, M. & Sato, E. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J. Hepatobiliary Pancreat Surg. 9, 328-341 (2002). (Pubitemid 34993681)
23. Moriya, T. et al. Biological similarities and differences between pancreatic intraepithelial neoplasias and intraductal papillary mucinous neoplasms. Int J. Gastrointest Cancer 35, 111-119 (2005). (Pubitemid 41272208)
24. Adsay, N. V et al. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am. J. Surg. Pathol. 27, 571-578 (2003). (Pubitemid 36514469)
25. Adsay, N. V et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am. J. Surg. Pathol. 28, 839-848 (2004). (Pubitemid 38856838)
26. Salvia, R. et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann. Surg. 239, 678-687 (2004). (Pubitemid 38525639)
27. Tollefson, M. K. et al. Intraductal papillary mucinous neoplasm: did it exist prior to 1980? Pancreas 26, e55-e58 (2003).
28. Ferrone, C R. et al. Current trends in pancreatic cystic neoplasms. Arch. Surg. 144, 448-454 (2009).
29. Sohn, T. A. et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann. Surg. 239, 788-799 (2004). (Pubitemid 38669430)
30. Sato, N. et al. STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am. J. Pathol. 159, 2017-2022 (2001). (Pubitemid 33104257)
31. Chetty, R. et al. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis. Hum. Pathol. 37, 212-217 (2006). (Pubitemid 43099842)
32. Brune, K. et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am. J. Surg. Pathol. 30, 1067-1076 (2006). (Pubitemid 44299338)
33. Fernández-del Castillo, C., Alsfasser, G., Targarona, J., Brugge, W. R. & Warshaw, A. L Serum CA 19-9 in the management of cystic lesions of the pancreas. Pancreas 32, 220 (2006).
34. Bosman, F. T., Carneiro, F., Hruban, R. & Theise, N. WHO Classification of Tumours of the Digestive System (World Health Organization, Lyon, 2010).
35. Adsay, N. V et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am. J. Surg. Pathol. 25, 26-42 (2001). (Pubitemid 32001830)
36. Crippa, S. et al. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiological characteristics. Clin. Gastroenterol. Hepatol. 8, 213-219 (2010).
37. Rodriguez, J. R. et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 133, 72-79 (2007). (Pubitemid 47031144)
38. Salvia, R. et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut 56, 1086-1090 (2007). (Pubitemid 47123238)
39. Chari, S. T. et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 123, 1500-1507 (2002). (Pubitemid 35231650)
40. Kobayashi, G. et al. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS. J. Gastroenterol. 40, 744-751 (2005). (Pubitemid 41349087)
41. Salvia, R. et al. Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts. Am. J. Surg. 198, 709-714 (2009).
42. Reid-Lombardo, K. M., Mathis, K. L., Wood, C M., Harmsen, W. S. & Sarr, M. G. Frequency of extrapancreatic neoplasms in intraductal papillary mucinous neoplasm of the pancreas: implications for management. Ann. Surg. 251, 64-69 (2010).
43. Fritz, S. et al. Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma. Ann. Surg. 249, 440-447 (2009).
44. Schönleben, F et al. BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas. Cancer Lett. 249, 242-248 (2007). (Pubitemid 46452934)
45. Iacobuzio-Donahue, C A. et al. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am. J. Pathol. 157, 755-761 (2000). (Pubitemid 32109368)
46. Sahin, F et al. Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms. Mod. Pathol. 16, 686-691 (2003). (Pubitemid 36871502)
47. Schönleben, F et al. PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas. Clin. Cancer Res. 12, 3851-3855 (2006). (Pubitemid 44000267)
48. Sato, N. et al. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am. J. Pathol. 164, 903-914 (2004). (Pubitemid 38235472)
49. Cubilla, A. L & Fitzgerald, P J. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res. 36, 2690-2698 (1976).
50. Klimstra, D. S. Cystic, mucin-producing neoplasms of the pancreas: the distinguishing features of mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Semin. Diagn. Pathol. 22, 318-329 (2005). (Pubitemid 44118642)
51. Crippa, S. et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann. Surg. 247, 571-579 (2008). (Pubitemid 351440607)
52. Buscaglia, J. M. et al. Patient-and cyst-related factors for improved prediction of malignancy within cystic lesions of the pancreas. Pancreatology 9, 631-638 (2009).
53. Garcea, G. et al. Cystic lesions of the pancreas. A diagnostic and management dilemma. Pancreatology 8, 236-251 (2008). (Pubitemid 351832476)
54. Fernández-del Castillo, C Mucinous cystic neoplasms. J. Gastrointest. Surg. 12, 411-413 (2008).
55. Wilentz, R. E., Albores-Saavedra, J. & Hruban, R. H. Mucinous cystic neoplasms of the pancreas. Semin. Diagn. Pathol. 17, 31-42 (2000). (Pubitemid 30132097)
56. Wilentz, R. E. et al. Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas. Am. J. Surg. Pathol. 23, 1320-1327 (1999). (Pubitemid 29517325)
57. Yamao, K. et al. Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian-type stroma: a multi-institutional study of the Japan pancreas society. Pancreas 40, 67-71 (2011).
58. Jimenez, R. E. et al. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy. Ann. Surg. 230, 501-511 (1999). (Pubitemid 30191845)
59. Iacobuzio-Donahue, C A. et al. Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression. Am. J. Surg. Pathol. 24, 1544-1548 (2000).
60. Lüttges, J., Feyerabend, B., Buchelt, T., Pacena, M. & Klöppel, G. The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am. J. Surg. Pathol. 26, 466-471 (2002). (Pubitemid 34280119)
61. Fukushima, N. et al. Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays. Oncogene 23, 9042-9051 (2004). (Pubitemid 40013071)
62. Ornitz, D. M., Hammer, R. E., Messing, A., Palmiter, R. D. & Brinster, R. L. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science 238, 188-193 (1987). (Pubitemid 17139719)
63. Quaife, C J., Pinkert, C A., Ornitz, D. M., Palmiter, R. D. & Brinster, R. L Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell 48, 1023-1034 (1987).
64. Hruban, R. H. et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res. 66, 95-106 (2006). (Pubitemid 43166014)
65. Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 4, 437-450 (2003). (Pubitemid 38050041)
66. Hingorani, S. R. et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 7, 469-483 (2005). (Pubitemid 40719130)
67. Bardeesy, N. et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad. Sci. USA 103, 5947-5952 (2006).
68. Pasca di Magliano, M. et al. Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev. 20, 3161-3173 (2006).
69. Siveke, J. T et al. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell. 12, 266-279 (2007). (Pubitemid 47333415)
70. Kojima, K. et al. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. Cancer Res. 67, 8121-8130 (2007). (Pubitemid 47395147)
71. Bardeesy, N. et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 20, 3130-3146 (2006). (Pubitemid 44790628)
72. Izeradjene, K. et al. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell. 11, 229-243 (2007). (Pubitemid 46349845)
73. Kamiyama, H. et al. In vivo and in vitro propagation of intraductal papillary mucinous neoplasms. Lab. Invest. 90, 665-673 (2010).
74. Sorio, C et al. Mucinous cystic carcinoma of the pancreas: a unique cell line and xenograft model of a preinvasive lesion. Virchows Arch. 446, 239-245 (2005). (Pubitemid 40558378)
75. Brugge, W. R., Lauwers, G. Y., Sahani, D., Fernández-del Castillo, C & Warshaw, A. L. Cystic neoplasms of the pancreas. N. Engl. J. Med. 351, 1218-1226 (2004).
76. Walsh, R. M. et al. Prospective preoperative determination of mucinous pancreatic cystic neoplasms. Surgery 132, 628-634 (2002). (Pubitemid 35247325)
77. Lewandrowski, K. B., Southern, J. F., Pins, M. R., Compton, C C & Warshaw, A. L. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, Serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma. Ann. Surg. 217, 41-47 (1993). (Pubitemid 23033217)
78. Allen, P J. et al. Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm. Ann. Surg. 250, 754-760 (2009).
79. Nagula, S. et al. Evaluation of cyst fluid CEA analysis in the diagnosis of mucinous cysts of the pancreas. J. Gastrointest Surg. 14, 1997-2003 (2010).
80. Raval, J. S. et al. Pancreatic lymphoepithelial cysts express CEA and can contain mucous cells: potential pitfalls in the preoperative diagnosis. Mod. Pathol. 23, 1467-1476 (2010).
81. Pelaez-Luna, M. & Chari, S. T Cyst fluid analysis to diagnose pancreatic cystic lesions: an as yet unfulfilled promise. Gastroenterology 130, 1007-1009 (2006). (Pubitemid 43374552)
82. Van der Waaij, L A., van Dullemen, H. M. & Porte, R. J. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest. Endosc 62, 383-389 (2005). (Pubitemid 41187940)
83. Khalid, A. et al. The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology Clin. Gastroenterol. Hepatol. 3, 967-973 (2005). (Pubitemid 41415743)
84. Schoedel, K. E., Finkelstein, S. D. & Ohori, N. P. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas. Diagn. Cytopathol. 34, 605-608 (2006). (Pubitemid 44298560)
85. Khalid, A. et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest. Endosc 69, 1095-1102 (2009).
86. Anderson, M. A., Kwon, R. S. & Scheiman, J. M. PANDA cyst-fluid analysis: eats, Shoots and leaves? Gastrointest. Endosc 69, 1103-1105 (2009).
87. Polkowski, M. Endoscopic ultrasonography Endoscopy 42, 68-72 (2010).
88. Habbe, N. et al. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol. Ther. 8, 340-346 (2009).
89. Hong, S. M. et al. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. Mod. Pathol. 21, 1499-1507 (2008).
90. Croce, C M. & Calin, G. A. miRNAs, cancer, and stem cell division. Cell 122, 6-7 (2005). (Pubitemid 40977933)
91. Szafranska, A. E. et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26, 4442-4452 (2007). (Pubitemid 47014466)
92. Lee, E. J. et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 120, 1046-1054 (2007).
93. Bloomston, M. et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297, 1901-1908 (2007). (Pubitemid 46707844)
94. Pelaez-Luna, M. et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. 102, 1759-1764 (2007). (Pubitemid 47206677)